Skip to main content
. Author manuscript; available in PMC: 2020 Apr 15.
Published in final edited form as: Cancer Cell. 2019 Apr 4;35(4):633–648.e7. doi: 10.1016/j.ccell.2019.03.003

Figure 7. Overexpression of UHRF1 is positively correlated with the methylation status of eight studied TSGs in human CRC tissues.

Figure 7.

(A-H) Kaplan-Meier analysis of the correlation of promoter methylation status of ICAM4 (A), PRSS8 (B), JDP2 (C), FBLN 2 (D), UCHL1 (E), p16 (F), LXN (G), and MATK (H) alone or together with UHRF1 expression with recurrence (left) and overall survival (right) in patients with CRC.

(I) The summary of the association between UHRF1 expression and the promoter methylation status of eight TSGs in 363 human CRC tissues.